SearchDictionaryMobileLogin

Hypothermia

9226  relevant articles (411 outcomes, 821 trials/studies) found for this Disease

Description: Lower than normal body temperature, especially in warm-blooded animals; in man usually accidental or unintentional.

Also Known As:
Hypothermia, Accidental; Accidental Hypothermia; Accidental Hypothermias; Hypothermias; Hypothermias, Accidental

Relationship Network

Disease Context: Research Results

Related Diseases

1. Ischemia
2. Heart Arrest (Cardiac Arrest)
3. Brain Injuries (Brain Injury)
4. Reperfusion Injury
5. Brain Ischemia (Cerebral Ischemia)

Experts

1. Kochanek, Patrick M: 8 articles (02/2008 - 05/2002)
2. Yenari, Midori A: 8 articles (07/2006 - 01/2002)
3. Steinberg, Gary K: 7 articles (03/2008 - 01/2002)
4. Rawls, Scott M: 6 articles (01/2008 - 05/2005)
5. Maekawa, Tsuyoshi: 5 articles (08/2008 - 03/2002)
6. Tisherman, Samuel A: 5 articles (02/2008 - 06/2002)
7. Cowan, Alan: 5 articles (01/2008 - 05/2005)
8. Klichkhanov, N K: 5 articles (03/2007 - 03/2000)
9. Hachimi-Idrissi, Said: 5 articles (12/2005 - 10/2003)
10. Zhao, Heng: 4 articles (03/2008 - 02/2004)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Hypothermia:
1. OxygenIBA
2. PotassiumIBA
3. Glucose (Dextrose)FDA LinkGeneric
4. Adenosine Triphosphate (ATP)IBA
5. Pentobarbital (Nembutal)FDA Link
6. Cardioplegic SolutionsIBA
7. CalciumIBA
8. Ethanol (Ethyl Alcohol)IBA
9. Glutamic Acid (Glutamate)FDA Link
10. Lactic AcidFDA LinkGeneric

Therapies and Procedures

1. Induced Heart Arrest (Cardioplegia)
08/01/1992 - "The findings suggest that, even though no consensus exists about its ideal composition, cardioplegia in conjunction with hypothermia is currently the strategy most often used for pediatric myocardial protection."
01/01/1987 - "Cardioplegia is most effective when combined with the additive properties of hypothermia, which plays a significant role in decreasing myocardial metabolism"
09/01/1996 - "RESULTS: In hypertrophied hearts, protection by topical hypothermia alone resulted in significantly improved postischemic recoveries of maximum left ventricular pressure and rate of pressure rise compared with the method of slow cooling or application of cardioplegia (40.6% +/- 5.0% and 38.1% +/- 5.9%, mean +/- standard error of the mean; p < 0.05)"
03/01/1983 - "The small increase in risk compared to the significant improvement from the combined approach has led to the following principles: coronary arteriography on all adult patients requiring valvular operations; bypass of all significant coronary lesions; restoration of valvular function and hemodynamics; and myocardial preservation with cold cardioplegia during a single period of cross clamping, topical cold, and systemic hypothermia."
12/01/1992 - "These techniques deviate from conventional practice, and they infer that normothermia is superior to hypothermia, retrograde cardioplegia is more advantageous than antegrade administration, and continuous cardioplegic delivery is preferable to intermittent dosage"
Order ALL the reference details at left...
2. Rewarming
3. Cardiopulmonary Bypass (Heart-Lung Bypass)
4. Resuscitation
5. Induced Hypothermia

Best Treatments:
Research Summary Report
on Hypothermia

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 411 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>